Hepatoprotective activity of brown algaPadina boergesenii against CCl4 induced oxidative damage in W

来源 :亚太热带医药杂志(英文版) | 被引量 : 0次 | 上传用户:fredric_cn
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To investigate the protective effects of brown algaPadina boergesenii(P. boergeseii) against carbon tetrachloride(CCl4) induced oxidative damage and liver fibrosis in rats.Methods:To assess the hepatic damage liver weight, the activities of TBARS level, glutathione,SOD, CAT andGPx in circulation and liver.Results:The group of rats induced withCCl4 alone (2 mL/kg body weight), showed noticeable increase in the liver weight and TBARS level. Followed by, the level of antioxidant enzymes glutathione peroxidase, Superoxide dismutase and catalase was also significantly(P<0.01) diminished. Where as, the rats pretreated withP. boergesenii (150 mg/kg body weight) modulated theCCl4induced liver fibrosis. The level of antioxidant enzymes and lipid peroxidation products was found to be significantly(P<0.01) attenuated to near normal level, when compared with rats induced withCCl4alone. In order to assess the role of carotenoids in the relevant activity, total carotenoid content of the extract was analysed and found to be0.59 mg/g fresh weight (FW). Further, the histopathogical studies provide a supportive evidence for this study to show the protective nature ofP. boergesenii.Conclusions: The protective role of brown algaP. boergesenii extract has confirmed its potential activity through its antioxidant sparing actions against CCl4 induced free radical damage. However, the possible mechanism of hepatoprotection is rather speculative at this stage and investigations are underway to isolate and characterize the bioactive compounds fromP. boergesenii.
其他文献
目的 讨论PDCA护理管理模式在种植牙围手术期护理的效果.方法 选取本院收治的106例种植牙手术患者作为本次研究的观察对象,并随机将其分为对照组(常规护理)与研究组(PDCA护理
1例16岁女性中学生为参加体能测试人工调整月经周期,遵医嘱口服黄体酮软胶囊100 mg、2次/d,连续用药13 d,同期未服用其他药物。停药后第4天,患者双眼视物出现双影,神经科和眼科检查均未见异常,考虑可能为精神紧张所致,未予治疗。患者自行应用七叶洋地黄双苷滴眼液(1滴/次,3次/d)和好视力眼贴(双侧太阳穴部位,1次/d,每次保留8 min),13 d后复视症状明显好转,7个月后症状完全消失。
白介素21(IL-21)是最新发现的与白介素2,白介素14和白介素15结构和序列同源的细胞因子.对于T细胞、B细胞和NK细胞有提高免疫应答等多种生物学活性.所以白介素21特别是人源白
目的探讨新生儿发生低血糖的相关危险因素,为预防新生儿低血糖的发生提供依据。方法回顾性分析120例低血糖新生儿(病例组)和120例血糖正常新生儿(对照组)的临床资料,对低血糖相关危险因素采用多因素Logistic回归分析。结果病例组低出生体质量儿、小于胎龄儿、早产、母亲妊娠期糖尿病、新生儿窒息和红细胞增多症明显多于对照组(35例比13例、21例比6例、31例比11例、13例比4例、27例比15例和1
期刊
期刊
目的探讨双导管法在输尿管狭窄硬性扩张中的临床应用价值。方法对51例采用双导管法行硬性扩张的输尿管狭窄患者的临床资料进行回顾性分析。结果51例患者中,输尿管镜成功通过狭窄段46例(90.2%),所有病例术中均未见输尿管穿孔或撕裂。未成功通过狭窄段的5例患者中,留置双J管2例,行经皮肾镜碎石取石2例,二期行输尿管狭窄段切除再接1例。术后3个月复查超声,患者的肾积水情况均有不同程度缓解。结论双导管法作为
Standard parenteral nutrition solutions are mixtures comprising interacting components that may de-grade themselves over time. The objective of this study was t
1例15岁慢性粒细胞白血病男性患儿因急变为急性淋巴细胞白血病合并中枢神经系统白血病给予达沙替尼50 mg口服,2次/d。用药1年后患儿出现部分头发、眉毛颜色变白;15个月后因腹泻停用达沙替尼,改为口服甲磺酸伊马替尼400 mg/d。停用达沙替尼2个月后患儿毛发明显转黑。1周后因疾病进展再次给予达沙替尼(50 mg,2次/d),6个月后部分头发、眉毛变白再次出现。
目的探究阻塞性睡眠呼吸暂停低通气综合征患者持续气道正压通气的远期依从状况。方法回顾性分析62例阻塞性睡眠呼吸暂停低通气综合征患者的临床资料。依据患者持续气道正压通气治疗12个月的依从性将患者分为依从性好组(34例)和依从性差组(28例)。分析持续气道正压通气治疗依从性差的原因和患者持续气道正压通气治疗依从性差的远期危险因素。结果依从性差的28例患者中断持续气道正压通气治疗的主要原因为行持续正压通气